499 related articles for article (PubMed ID: 28165066)
1. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
2. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Cell Biochem Funct; 2018 Jun; 36(4):194-202. PubMed ID: 29653464
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
6. MiR-202-5p/
Liu T; Guo J; Zhang X
Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
[TBL] [Abstract][Full Text] [Related]
7. MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway.
Shen H; Wang D; Li L; Yang S; Chen X; Zhou S; Zhong S; Zhao J; Tang J
Gene; 2017 Jan; 596():110-118. PubMed ID: 27746366
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
9. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
11. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
[TBL] [Abstract][Full Text] [Related]
12. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis.
Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA
Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling.
Yin Y; Wang X; Li T; Ren Q; Li L; Sun X; Zhang B; Wang X; Han H; He Y; Cao Z; Sun X; Zhou Z
Cancer Med; 2020 Feb; 9(4):1544-1552. PubMed ID: 31899608
[TBL] [Abstract][Full Text] [Related]
15. Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.
Gao C; Yuan X; Jiang Z; Gan D; Ding L; Sun Y; Zhou J; Xu L; Liu Y; Wang G
Breast Cancer Res Treat; 2019 Jul; 176(2):291-301. PubMed ID: 31006103
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microRNA-130b inhibits glioma cell proliferation and invasion, and induces apoptosis by PTEN/AKT signaling.
Gu JJ; Fan KC; Zhang JH; Chen HJ; Wang SS
Int J Mol Med; 2018 Jan; 41(1):284-292. PubMed ID: 29115407
[TBL] [Abstract][Full Text] [Related]
17. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
Zhu L; Wang X; Wang T; Zhu W; Zhou X
Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
[TBL] [Abstract][Full Text] [Related]
18. MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer.
Li N; Miao Y; Shan Y; Liu B; Li Y; Zhao L; Jia L
Cell Death Dis; 2017 May; 8(5):e2796. PubMed ID: 28518139
[TBL] [Abstract][Full Text] [Related]
19. MiR-548k suppresses apoptosis in breast cancer cells by affecting PTEN/PI3K/AKT signaling pathway.
Yadollahi-Farsani M; Amini-Farsani Z; Moayedi F; Khazaei N; Yaghoobi H
IUBMB Life; 2023 Feb; 75(2):97-116. PubMed ID: 36309967
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway.
Fu X; Liu M; Qu S; Ma J; Zhang Y; Shi T; Wen H; Yang Y; Wang S; Wang J; Nan K; Yao Y; Tian T
J Exp Clin Cancer Res; 2018 Mar; 37(1):52. PubMed ID: 29530052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
